Statins and oxidative stress in the cardiovascular system

Statins and oxidative stress in the cardiovascular system

Statins are widely established as an important class of medications for primary and secondary prevention of cardiovascular disease. In addition to their lipid-lowering effects, mounting evidence suggests that statins exhibit non-lipid-lowering mediated effects in the cardiovascular system. These so...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Margaritis, M, Sanna, F, Antoniades, C
Fformat:	Journal article
Cyhoeddwyd:	Bentham Science Publishers 2017

Eitemau Tebyg

Perivascular adipose tissue as an endocrine organ: the role of statins
gan: Sanna, F, et al.
Cyhoeddwyd: (2017)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
gan: Margaritis, M, et al.
Cyhoeddwyd: (2012)

Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations.
gan: Lee, R, et al.
Cyhoeddwyd: (2012)

Statins and vein graft failure in coronary bypass surgery.
gan: Margaritis, M, et al.
Cyhoeddwyd: (2012)

Statins and vein graft failure in coronary bypass surgery
gan: Margaritis, M, et al.
Cyhoeddwyd: (2012)

Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering.
gan: Margaritis, M, et al.
Cyhoeddwyd: (2014)

Statins: pleiotropic regulators of cardiovascular redox state.
gan: Antoniades, C, et al.
Cyhoeddwyd: (2014)

Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2012)

Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2012)

Statins Decrease Oxidative Stress and ICD Therapies
gan: Heather L. Bloom, et al.
Cyhoeddwyd: (2010-01-01)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
gan: Akoumianakis, I, et al.
Cyhoeddwyd: (2018)

Blood telomere length predicts clinical outcome after acute myocardial infarction: The role of oxidative stress
gan: Margaritis, M, et al.
Cyhoeddwyd: (2016)

Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?
gan: Tousoulis, D, et al.
Cyhoeddwyd: (2008)

Statin treatment, oxidative stress and inflammation in a Danish population
gan: Anders L. Sørensen, et al.
Cyhoeddwyd: (2019-02-01)

Statins and antioxidant vitamins: should co-administration be avoided?
gan: Tousoulis, D, et al.
Cyhoeddwyd: (2006)

Statins in primary prophylaxis of cardiovascular diseases
gan: Zhanna Davidovna Kobalava, et al.
Cyhoeddwyd: (2011-09-01)

Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
gan: Tousoulis, D, et al.
Cyhoeddwyd: (2008)

Effect of plant sterols compared with ezetimibe on oxidative stress in patients treated with statins
gan: Adriana Bertolami, et al.
Cyhoeddwyd: (2014-09-01)

The impact of statin administration in acute coronary syndromes.
gan: Papageorgiou, N, et al.
Cyhoeddwyd: (2010)

Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
gan: Enrique C. Morales-Villegas, et al.
Cyhoeddwyd: (2011-01-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
gan: S. Y. Martsevich, et al.
Cyhoeddwyd: (2016-01-01)

Effect of statin add-on therapy on cardiovascular mortality
gan: John R. Nelson, et al.
Cyhoeddwyd: (2024-03-01)

Cardiovascular Risk and Statin Therapy Considerations in Women
gan: Gina Gheorghe, et al.
Cyhoeddwyd: (2020-07-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
gan: S. Y. Martsevich, et al.
Cyhoeddwyd: (2016-01-01)

New paradigm of treatment with statins in cardiovascular prevention
gan: Carlo Vigorito, et al.
Cyhoeddwyd: (2016-01-01)

Statins for people at low risk of cardiovascular disease reply
gan: Mihaylova, B, et al.
Cyhoeddwyd: (2012)

Insulin triggers oxidative stress in the vascular wall of patients with atherosclerosis, independently of systemic insulin resistance: the beneficial role of DPP-IV inhibition
gan: Akoumianakis, I, et al.
Cyhoeddwyd: (2018)

Insulin induces oxidatives stress in the vascular wall of patients with atherosclerosis independently of systemic insulin resistance: the regulatory role of DPP4 inhibition
gan: Akoumianakis, I, et al.
Cyhoeddwyd: (2018)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
gan: N. F. Puchin'yan, et al.
Cyhoeddwyd: (2015-12-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
gan: N. F. Puchin'yan, et al.
Cyhoeddwyd: (2015-12-01)

Benefits of statin therapy and compliance in high risk cardiovascular patients
gan: Joel A Lardizabal, et al.
Cyhoeddwyd: (2010-09-01)

Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
gan: Pratibha Singh, et al.
Cyhoeddwyd: (2020-12-01)

Rheumatoid arthritis: RA-lowering cardiovascular risk with statins
gan: Lee, J, et al.
Cyhoeddwyd: (2010)

Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.
gan: Lee, J, et al.
Cyhoeddwyd: (2010)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
gan: D. A. Anichkov, et al.
Cyhoeddwyd: (2015-12-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
gan: A. E. Semenova, et al.
Cyhoeddwyd: (2018-06-01)

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
gan: Cheng Yang, et al.
Cyhoeddwyd: (2023-12-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
gan: D. A. Anichkov, et al.
Cyhoeddwyd: (2015-12-01)

Clinical efficacy and safety of statins in managing cardiovascular risk
gan: Navin K Kapur, et al.
Cyhoeddwyd: (2008-04-01)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
gan: Marina G. Bubnova, et al.
Cyhoeddwyd: (2021-06-01)